DEVICE CATEGORY · NIU
Stent, Superficial Femoral Artery, Drug-Eluting
Stent, Superficial Femoral Artery, Drug-Eluting -- a metal scaffold with a drug coating placed via a delivery catheter into the superficial femoral artery artery to maintain the lumen. The drug coating is intended to inhibit restenosis.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Zilver PTX Drug-Eluting Peripheral StentP100022/S046 | Cook Ireland, Ltd. | PMA supplement | Nov 6, 2026 | FDA |
ELUVIA Drug-Eluting Vascular Stent SystemP180011/S070 | Boston Scientific Corp | PMA supplement | Aug 21, 2026 | FDA |
Eluvia Drug-Eluting Vascular Stent SystemP180011/S069 | Boston Scientific Corp | PMA supplement | Aug 6, 2026 | FDA |
Zilver PTX Drug-Eluting Peripheral StentP100022/S045 | Cook Ireland, Ltd. | PMA supplement | Mar 25, 2026 | FDA |
Eluvia Drug-Eluting Vascular Stent SystemP180011/S060 | Boston Scientific Corp | PMA supplement | Jan 30, 2026 | FDA |
Eluvia Drug-Eluting Vascular Stent SystemP180011/S067 | Boston Scientific Corp | PMA supplement | Oct 24, 2025 | FDA |
Eluvia Drug-Eluting Vascular Stent SystemP180011/S066 | Boston Scientific Corp | PMA supplement | Aug 8, 2025 | FDA |
| Cook Ireland, Ltd. | PMA approval | Nov 14, 2012 | FDA |
Source information
Follow the FDA links to view the original records.



